TVTX 241220 7.50C (TVTX241220C7500) Stock Options, News & Quotes

US OptionsDetailed Quotes

TVTX241220C7500

Watchlist

12.43
+1.63+15.09%

15min DelayClose Dec 3 15:59 ET

12.73High12.13Low

Intraday

5D
Daily

News

In 2025, US Biotech stocks are expected to rise significantly. jpmorgan's top pick is vertex pharmaceuticals (VRTX.US).
Vertex pharmaceuticals (Vertex) ranked first on the list of US biotechnology stock selections for 2025 released by jpmorgan.
Zhitong FinanceNov 26 02:22 ET
Insider Sale: SVP of $TVTX (TVTX) Sells 12,090 Shares
Quiver QuantitativeNov 25 21:15 ET
Vertex Leads J.P. Morgan's Top Biotech Picks List for 2025
Seeking AlphaNov 25 15:10 ET
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Seeking AlphaNov 25 13:58 ET
Travere Therapeutics (TVTX) Gets a Buy From J.P. Morgan
TipRanksNov 21 07:05 ET · Ratings
Express News | Travere Therapeutics Inc : JP Morgan Cuts Target Price to $42 From $43
ReutersNov 20 00:28 ET

Comments

Jaguar8

Nov 4 13:02

NEWS 13G

$Travere Therapeutic (TVTX.US)$
Travere Therapeutic | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.02%)

Stock_Drift

Oct 26 08:40

Earnings on 10/31 👻🎃

$Travere Therapeutic (TVTX.US)$

MMu

Oct 17 13:03

$Travere Therapeutic (TVTX.US)$ They got the europe approval as well! When is the next event date? @anyone

MMu

Oct 14 14:06

$Travere Therapeutic (TVTX.US)$
Someone buying large blocks 150k, 50k....
Does anybody know what's going on?

Jaguar8

Sep 26 15:03

NEWS

$Travere Therapeutic (TVTX.US)$
Travere Therapeutics Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase Related to Commercial Manufacturing Scale-Up
SAN DIEGO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ:TVTX) today announced a voluntary pause of enrollment in the Phase 3 HARMONY Study evaluating pegtibatinase for the treatment of classical homocystinuria (HCU). The voluntary enrollment pause enables the Company to work to address ...